β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-08
DOI
10.3389/fbioe.2020.00378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
- (2020) Giulia Petroni et al. Cell Death & Disease
- The Role of p53-Mediated Signaling in the Therapeutic Response of Colorectal Cancer to 9F, a Spermine-Modified Naphthalene Diimide Derivative
- (2020) Lei Gao et al. Cancers
- Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study
- (2020) Ian Chau et al. Cancers
- Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway
- (2019) Meng-Yao Sun et al. Cancer Management and Research
- Apoptotic Effect of Saccharomyces cerevisiae on Human Colon Cancer SW480 Cells by Regulation of Akt/NF-ĸB Signaling Pathway
- (2019) Sara Shamekhi et al. Probiotics and Antimicrobial Proteins
- The multiple mechanisms that regulate p53 activity and cell fate
- (2019) Antonina Hafner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanism of bioactive polysaccharide from Lachnum sp. acts synergistically with 5-fluorouracil against human hepatocellular carcinoma
- (2019) Shuai Zong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PD-016Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study
- (2019) A Raimondi et al. ANNALS OF ONCOLOGY
- Targeting Autophagy in Cancer: Recent Advances and Future Directions
- (2019) Ravi K. Amaravadi et al. Cancer Discovery
- The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway
- (2018) Tong Zhang et al. CANCER LETTERS
- A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation
- (2018) Gal Chaim Nuta et al. Autophagy
- Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells
- (2018) Eswara Murali Satyavarapu et al. Cell Death & Disease
- Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
- (2018) Mamiko Imanishi et al. CANCER SCIENCE
- Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
- (2018) Bingtao Zhai et al. International Journal of Nanomedicine
- Discovery of novel antitumor nitric oxide-donating β -elemene hybrids through inhibiting the PI3K/Akt pathway
- (2017) Jichao Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection
- (2017) Ying Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of autophagy in regulating the radiosensitivity of tumor cells
- (2017) Yong Xin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival
- (2017) Haizhen Wang et al. NATURE
- P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting
- (2017) Prashanth Gokare et al. Scientific Reports
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency
- (2016) Muhammad Wasif Saif et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Comparative efficacy of whole-brain radiotherapy with and without elemene liposomes in patients with multiple brain metastases from non-small-cell lung carcinoma
- (2016) Y.N. Sun et al. Current Oncology
- β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway
- (2016) Lin Mu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An Autophagic Flux Probe that Releases an Internal Control
- (2016) Takeshi Kaizuka et al. MOLECULAR CELL
- β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1
- (2016) Hai-bin Feng et al. Stem Cells Translational Medicine
- Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2′-deoxy-5-fluorouridine into DNA
- (2015) KAZUKI SAKAMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease
- (2015) Carolina Alquézar et al. JOURNAL OF NEUROCHEMISTRY
- Inhibition of tumor growth by β-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model
- (2015) Hong Shi et al. MELANOMA RESEARCH
- JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
- (2014) Xinbing Sui et al. Scientific Reports
- β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
- (2013) QUENTIN Q. LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
- (2013) Q. Quentin Li et al. MEDICAL ONCOLOGY
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
- (2013) X Sui et al. Cell Death & Disease
- Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
- (2012) Zhengzhi Zou et al. Autophagy
- Tumor Cell Autophagy as an Adaptive Response Mediating Resistance to Treatments Such as Antiangiogenic Therapy
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- p53 signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment
- (2011) Xinbing Sui et al. Autophagy
- Cbl-regulated Akt and ERK signals are involved in β-elemene-induced cell apoptosis in lung cancer cells
- (2011) Xuejun Hu Molecular Medicine Reports
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Antineoplastic effect ofβ-elemene on prostate cancer cells and other types of solid tumour cells
- (2010) Qingdi Quentin Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Eaten alive: a history of macroautophagy
- (2010) Zhifen Yang et al. NATURE CELL BIOLOGY
- An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas
- (2009) Xue Shen Wu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation
- (2008) Yi-Qun Yao et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started